| Intrinsic Valuation of: AGNCN | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | -2 | Market Cap | $9B | |||||
| 2021 | - | - (-) | P/E Ratio | - | Total Asset | $88B | |||||
| 2022 | $2B | - (-) | Net Income | $863M | Total Debt | $64M | |||||
| 2023 | $1B | -34.2% (-149.3%) | EBITDA | - | Total Liab | $78B | |||||
| 2024 | $-118M | -111.6% (48.2%) | Opr Margin | - | Debt/Equity | 0.01 | |||||
| 2025 | $86M | 172.9% (118.8%) | PreTax Margin | - | BV/Share | 16 | |||||
| 5Y Average FCF | $630M | 9.0% (5.9%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (9.0%) | ||||||||||
| 2026 | $94M | MBG Intrinsic Value | $-17 | ||||||||
| 2027 | $102M | ||||||||||
| 2028 | $111M | ||||||||||
| 2029 | $121M | ||||||||||
| 2030 | $132M | ||||||||||
| 2031 | $144M | ||||||||||
| Terminal Value | $3B | Net Worth/Share | $20 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $2B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $505M | $6 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $64M | WACC | 7.3% | 6 | 6 | 6 | 7 | 7 | |||
| Equity Value | $3B | 7.4% | 5 | 6 | 6 | 7 | 7 | ||||
| Shares Outstanding | 477,832,000 | 7.4% | 5 | 6 | 6 | 7 | 7 | ||||
| 7.9% | 5 | 5 | 6 | 6 | 7 | ||||||
| DCF Intrinsic Value | $6 | 8.4% | 5 | 5 | 5 | 6 | 6 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||